日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?

肠道菌群组成与心血管疾病：潜在的新治疗靶点？

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241511971
Belli, Martina; Barone, Lucy; Longo, Susanna; Prandi, Francesca Romana; Lecis, Dalgisio; Mollace, Rocco; Margonato, Davide; Muscoli, Saverio; Sergi, Domenico; Federici, Massimo; Barillà, Francesco
心血管
心血管疾病
微生物学
肠道菌群
发表日期：2023
文献求助 收藏

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future

动脉粥样硬化的免疫调节疗法：过去、现在和未来

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241310979
Lecis, Dalgisio; Massaro, Gianluca; Benedetto, Daniela; Di Luozzo, Marco; Russo, Giulio; Mauriello, Alessandro; Federici, Massimo; Sangiorgi, Giuseppe Massimo
心血管
动脉粥样硬化
免疫/内分泌
发表日期：2023
文献求助 收藏

Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?

除了胰高血糖素样肽-1受体激动剂的心血管效应之外：瘦身和斑块稳定。新一代他汀类药物诞生了吗？

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom13121695
Lecis, Dalgisio; Prandi, Francesca Romana; Barone, Lucy; Belli, Martina; Sergi, Domenico; Longo, Susanna; Muscoli, Saverio; Romeo, Francesco; Federici, Massimo; Lerakis, Stamatios; Barillà, Francesco
信号转导
发表日期：2023
文献求助 收藏

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?

SGLT2 抑制剂以外的 HFpEF 治疗：添加 GLP-1 RA 能否改善糖尿病患者的心血管代谢风险和预后？

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms232314598
Belli, Martina; Barone, Lucy; Bellia, Alfonso; Sergi, Domenico; Lecis, Dalgisio; Prandi, Francesca Romana; Milite, Marialucia; Galluccio, Chiara; Muscoli, Saverio; Romeo, Francesco; Barillà, Francesco
代谢
GLP-1
糖尿病
SGLT2
发表日期：2022
文献求助 收藏

Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers

糖尿病诱发冠状动脉疾病中的表观遗传修饰和非编码RNA：病理生理联系和新的治疗前沿

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms23094589
Prandi, Francesca Romana; Lecis, Dalgisio; Illuminato, Federica; Milite, Marialucia; Celotto, Roberto; Lerakis, Stamatios; Romeo, Francesco; Barillà, Francesco
糖尿病
表观遗传
代谢
发表日期：2022
文献求助 收藏

Biomolecular Mechanisms of Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors

钠-葡萄糖协同转运蛋白2抑制剂发挥心肾保护作用的生物分子机制

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom12101349
Prandi, Francesca Romana; Barone, Lucy; Lecis, Dalgisio; Belli, Martina; Sergi, Domenico; Milite, Marialucia; Lerakis, Stamatios; Romeo, Francesco; Barillà, Francesco
发表日期：2022
文献求助 收藏

Clinical Features and Management of COVID-19-Associated Hypercoagulability

COVID-19相关高凝状态的临床特征及治疗

期刊:Cardiac Electrophysiology Clinics
影响因子:
doi:10.1016/j.ccep.2021.10.005
Massaro, Gianluca; Lecis, Dalgisio; Martuscelli, Eugenio; Chiricolo, Gaetano; Sangiorgi, Giuseppe Massimo
发表日期：2022
文献求助 收藏

Inflammation in atherosclerotic cardiovascular disease

动脉粥样硬化性心血管疾病中的炎症

期刊:F1000Research
影响因子:
doi:10.12688/f1000research.18901.1
Shah, Prediman K; Lecis, Dalgisio
炎症
炎症/感染
心血管疾病
Immunology/Inflammation
心血管
动脉粥样硬化
发表日期：2019
文献求助 收藏